Cas:1131594-24-5 3-Bromo-4-morpholinobenzoic Acid manufacturer & supplier

We serve Chemical Name:3-Bromo-4-morpholinobenzoic Acid CAS:1131594-24-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-Bromo-4-morpholinobenzoic Acid

Chemical Name:3-Bromo-4-morpholinobenzoic Acid
CAS.NO:1131594-24-5
Synonyms:3-bromo-4-morpholin-4-ylbenzoic acid;3-Bromo-4-morpholinobenzoic acid
Molecular Formula:C11H12BrNO3
Molecular Weight:286.12200
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:49.77000
Exact Mass:285.00000
LogP:2.04890

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-bromo-4-morpholin-4-ylbenzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Bromo-4-morpholinobenzoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Bromo-4-morpholinobenzoic acid Use and application,3-Bromo-4-morpholinobenzoic acid technical grade,usp/ep/jp grade.


Related News: The Department of Health and Human Services asked the Defense Department to provide several facilities capable of housing at least 250 people in individual rooms through to February 29, the Pentagon said. 3-Bromo-4-morpholinobenzoic Acid manufacturer One key question for the fixed-duration combo is whether it can sustain remission after treatment has stopped. In the preliminary analysis of the GLOW trial, at three months after treatment ended, 51.9% of the Imbruvica-Venclexta patients had undetectable measurable residual disease (uMRD)—a stringent marker reflecting no signs of cancer—in bone marrow, versus 17.1% for the control group. The rates for peripheral blood were 54.7% and 39% for the two groups, respectively. 3-Bromo-4-morpholinobenzoic Acid supplier The Department of Health and Human Services asked the Defense Department to provide several facilities capable of housing at least 250 people in individual rooms through to February 29, the Pentagon said. 3-Bromo-4-morpholinobenzoic Acid vendor Rates of breast cancer-related genetic mutations in Black and white women are the same, according to a new study that contradicts previous research. 3-Bromo-4-morpholinobenzoic Acid factory The Department of Health and Human Services asked the Defense Department to provide several facilities capable of housing at least 250 people in individual rooms through to February 29, the Pentagon said.